Biliary Tract Neoplasms
- 1st Edition - September 1, 2025
- Imprint: Elsevier
- Editors: Timothy M. Pawlik, Shishir K. Maithel
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 9 2 8 7 - 3
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 9 2 8 8 - 0
Biliary Tract Neoplasms is a state-of-art reference of the multimodality management of bile duct cancer written by leaders in the field. As targeted therapy and clinical trials… Read more
Purchase options
Biliary Tract Neoplasms is a state-of-art reference of the multimodality management of bile duct cancer written by leaders in the field. As targeted therapy and clinical trials in this field are exploding, and the incidence of the disease is increasing, now is the time to address the topic in practical manner. This reference addresses surgical approaches to biliary neoplasms, targeted personalized systemic approaches to biliary neoplasms, and other treatment modalities such as radiotherapy and ablation. It is intended for scientists, researchers, clinicians, practicing surgeons, surgical oncologists, transplant surgeons as well as fellows/residents in the surgical space.
The book's translational nature and impact of basic science findings that have informed targeted therapy for biliary neoplasms provide the very latest data on surgery, medical, imaging, and multi-modality care of biliary neoplasm to educate and inform care of this patient population.
The book's translational nature and impact of basic science findings that have informed targeted therapy for biliary neoplasms provide the very latest data on surgery, medical, imaging, and multi-modality care of biliary neoplasm to educate and inform care of this patient population.
- Incudes the most recent information and research data on biliary tract neoplasms
- Describes in detail the sequence options of different therapies and risk factors in a clinical setting
- Presents a surgical perspective of personalized systemic approaches to biliary neoplasms for practical use
Basic Scientists, researchers, clinicians, surgeons, hepatologists, gastroenterologists, surgical oncologists, transplant surgeons, HPB surgeons, fellows and residents in the surgical space
1. Epidemiology
2. Risk Factors and Clinical Presentation of BTC
3. Radiologic Presentation of BTC
4. Pathologic Classification and Staging of BTC
5. Biliary Tract Decompression
6. Surgical Resection for Cholangiocarcinoma
7. Surgical Resection for Gallbladder Cancer
8. Systemic Therapy for BTC
9. Targeted Therapy for BTC
10. Optimizing Immunotherapy for BTC
11. Radiation therapy for BTC
12. Liver Directed Therapy
13. Sequencing of therapy
14. Evolving role of Transplantation
15. The Clinical Trials Landscape – The Future of BTC
2. Risk Factors and Clinical Presentation of BTC
3. Radiologic Presentation of BTC
4. Pathologic Classification and Staging of BTC
5. Biliary Tract Decompression
6. Surgical Resection for Cholangiocarcinoma
7. Surgical Resection for Gallbladder Cancer
8. Systemic Therapy for BTC
9. Targeted Therapy for BTC
10. Optimizing Immunotherapy for BTC
11. Radiation therapy for BTC
12. Liver Directed Therapy
13. Sequencing of therapy
14. Evolving role of Transplantation
15. The Clinical Trials Landscape – The Future of BTC
- Edition: 1
- Published: September 1, 2025
- Imprint: Elsevier
- Language: English
TP
Timothy M. Pawlik
Dr. Timothy M. Pawlik, MD, PhD, MPH, MTS, MBA, FACS, FSSO is the Chair of Surgery at The Ohio State University Wexner Medical Center where he holds The Urban Meyer III and Shelley Meyer Chair for Cancer Research. His research focuses on determinations of factors associated with prognosis and staging of gastrointestinal cancers with a particular focus on cholangiocarcinoma. He also studies patient/physician communication and patient engagement, as well as patient perception of cancer-care goals and the impact of social determinants of health. Dr. Pawlik is an active participant in multiple national and international surgical societies and has delivered talks on cholangiocarcinoma around the world.
Affiliations and expertise
Professor and Chair, Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, Professor of Surgery, Oncology, and Health Services Management and Policy, Surgeon in Chief, The Ohio State University Wexner Medical Center, Columbus, Ohio, USASM
Shishir K. Maithel
Dr. Shishir K. Maithel, MD, FACS, FSSO is the William T. Bovie Professor of Surgery, Chief of the Division of Surgical Oncology and Chief Surgical Oncology Officer of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Feinberg School of Medicine. His clinical and research interests focus on tumors of the bile ducts, as well as other gastrointestinal malignancies such as cancer of the liver, pancreas, stomach, colon, and small intestine. He is an active member of the Cholangiocarcinoma Foundation and is leading the effort in running novel clinical trials for patients with early-stage biliary cancers.
Affiliations and expertise
Professor, Division of Surgical Oncology, Department of Surgery of Emory University School of Medicine, USA